News & Analysis
AI-powered market intelligence from WelthWest Research Desk. Original analysis, not just news.
4344 articles · Page 132 of 362
InCred Holdings IPO: Why This Rs 1,250 Cr Filing Signals an NBFC Bull Run
InCred Holdings has updated its SEBI filing for a Rs 1,250 crore fresh issue, signaling a strategic pivot toward aggressive balance sheet expansion. This move highlights the resilience of the Indian non-banking financial sector and sets the stage for a competitive reshuffling among retail lenders.
2026 Tech Layoffs: Why Indian IT Stocks Are at a Strategic Crossroads
With over 93,000 tech jobs cut globally in 2026, the traditional IT services model is under unprecedented pressure. We analyze how Indian IT giants are navigating this transition and identify which stocks are positioned to capture the new wave of AI-led demand.
Middle East De-escalation: The Bull Run for Indian Equities Begins Now
As Iran-Israel tensions subside, the global risk-on sentiment is shifting capital back into emerging markets. With crude oil prices softening, Indian OMCs, aviation, and financial services stand to gain significantly. We analyze the sector rotation and actionable playbook for the next market cycle.
KPIT Technologies Q4 Earnings: Why Margin Compression Signals Sector Shift
KPIT Technologies' Q4 results highlight the hidden costs of scaling automotive software. We analyze the margin compression, the strategic implications of the Cymotive acquisition, and what this means for the broader Indian automotive engineering sector.
Skyroot Aerospace Hits Unicorn Status: What It Means for Indian Space Stocks
The rise of Skyroot Aerospace as India's first space-tech unicorn validates the government's liberalized space policy. We break down the winners, losers, and specific NSE stocks poised to benefit from the private orbital launch revolution.
SpaceX-Anthropic AI Deal: Why Indian IT Stocks Are at a Strategic Inflection
SpaceX and Anthropic have joined forces to scale AI compute, setting a new benchmark for hardware-software integration. This move forces a revaluation of Indian IT firms, separating those with specialized AI engineering capabilities from legacy service providers facing margin pressure.
Hawkeye 360’s $416M IPO: A Blueprint for India’s Space-Tech Defense Boom
Hawkeye 360’s massive IPO success has sent shockwaves through the global defense sector, signaling a permanent shift toward orbital surveillance. We analyze the implications for the Indian defense ecosystem, identifying which NSE/BSE stocks are poised to benefit from this intelligence-led investment cycle.
US-Iran De-escalation: Why Indian Stocks Are Primed for a Major Rally
Geopolitical cooling between the US and Iran is triggering a global risk-on sentiment, with India poised as a primary beneficiary. Lower crude oil prices are set to bolster current account balances and manufacturing margins. We analyze the specific sectors and stocks positioned to outperform as the energy risk premium evaporates.
MetLife’s PE Surge: Why Indian Insurance Stocks Are Primed for a Re-Rating
MetLife's recent earnings beat, driven by robust private equity performance, provides a blueprint for the future of insurance asset management. As global interest rates remain volatile, Indian insurers are increasingly looking toward alternative assets to protect margins. We break down the implications for HDFC Life, SBI Life, and the broader Indian insurance sector.
Adobe’s Agentic AI Shift: The Next Big Catalyst for Indian IT Stocks
Adobe is accelerating the adoption of agentic AI through its Indian R&D hubs, forcing a paradigm shift in enterprise productivity. This article analyzes the ripple effects across the Indian IT sector, identifying the winners and losers in the race to automate complex workflows.
M&A Boom: GameStop's $56B eBay Bid Ignites Indian Market Rally
The unprecedented $56 billion bid by GameStop for eBay marks a pivotal moment, heralding a new era of aggressive M&A driven by renewed risk appetite and abundant credit. This global resurgence is poised to significantly boost Indian markets, driving up valuations, attracting foreign investment, and favoring sectors ripe for consolidation. Prepare for a dynamic investment landscape.
Eli Lilly’s $9B Debt Spree: What This Means for Indian Pharma Stocks
Global pharma giant Eli Lilly has secured $9 billion in fresh capital to fuel an aggressive acquisition strategy focused on weight-loss and metabolic drugs. This massive liquidity injection is set to reshape the pharmaceutical landscape, creating significant opportunities and risks for the Indian pharmaceutical and contract manufacturing sectors.